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Abstract
Aims: This study aimed to determine effective predictive 
factors for primary postpartum hemorrhage (PPH) among 
clinical blood parameters associated with coagulation 
and fibrinolysis and demographic characteristics.
Methods: We retrospectively studied 1032 women who 
underwent determinations of clinical blood parameters at 
gestational week (GW) 29–32 and GW 35–37 and gave birth 
to singleton infants at our hospital between January 2011 
and December 2013. PPH was defined as estimated blood 
loss  ≥ 700 mL. Multivariate logistic regression analyses 
were used to determine independent risk factors and odds 
ratios (OR) for PPH.
Results: PPH occurred in 104 of 1032 women (10%). Three 
blood variables, fibrinogen level  < 4.0 g/L (OR [95% CI], 1.96 
[1.18–3.27]), antithrombin activity  < 85% of normal activ-
ity level (1.84 [1.05–3.21]), and D-dimer level  > 2.7 μg/mL 
(2.03 [1.29–3.19]) at GW 35–37, and three demographic 
characteristics, maternal age  ≥ 35  years (1.75 [1.15–2.68]), 
BMI  > 28.2 kg/m2 on admission for childbirth (1.95 [1.20–
3.16]), and previous cesarean delivery (2.77 [1.31–5.83]), 
were identified as independent risk factors for PPH.
Conclusion: Among blood parameters, higher D-dimer lev-
els and lower levels of antithrombin activity and fibrinogen 
in late gestation were independent risk factors for PPH.
Keywords: Antithrombin; d-dimer; fibrinogen; postpar-
tum hemorrhage.
Introduction
Primary postpartum hemorrhage (PPH) is the most 
common form of major obstetric hemorrhage and remains 
one of the major causes of maternal death in both devel-
oped and developing countries [1, 2]. In Japan, the mater-
nal mortality rate was 3.1 per 100,000 births in 2008, and 
PPH is the second most common direct cause of death 
[3, 4]. Among 151,866 women who delivered in 253 peri-
natal medical centers during 2012, 17.1% experienced 
more than 1000  mL of blood loss, and 0.7% more than 
3000  mL of blood loss [5]. The maternal mortality rate 
has been decreasing both in Japan and worldwide [4, 6], 
but an increasing trend in the rate of PPH was observed 
in developed countries including Australia, Canada, and 
the USA [7].
Once PPH has been identified, appropriate manage-
ment is needed, which depends on the woman receiving 
care in a consultant-led maternity unit with access to 
laboratory and blood bank facilities and skilled obstet-
ric and anesthetic staff readily available [2]. In Japan, 
approximately half of pregnant women give birth in hos-
pitals, and other half give birth in clinics with one or two 
obstetricians [8]. These clinics do not have easy access 
to laboratory and blood bank facilities and skilled staff. 
In order to better manage PPH, it is important for clini-
cians to predict the occurrence and severity of PPH before 
delivery.
Some known risk factors for PPH are placenta previa, 
previous PPH, Asian ethnicity, anemia, and preeclampsia. 
Recently, maternal coagulation and fibrinolysis profiles 
also have been investigated to predict severe postpartum 
hemorrhage. Although a correlation between the decrease 
of fibrinogen in the early phase of PPH and PPH severity 
has been reported [9, 10], there are few studies concern-
ing the prediction of PPH occurrence before delivery. The 
aim of the present study was to determine effective pre-
dictive factors for PPH using a combination of antenatal 
coagulation and fibrinolysis profiles and maternal clinical 
demographics.
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Materials and methods
This study was conducted after approval of the institutional review 
board and Ethics Committee at the University of Tsukuba Hospital 
was obtained (number: H26-216).
Participants
We retrospectively reviewed the clinical records of all 1347 women 
who met the following three conditions: (1) provided written 
informed consent for participation in this study, (2) had antenatal 
care on and after gestational week (GW) 32 at our clinic, and (3) gave 
birth vaginally to singleton infants on and after GW 35 at our hos-
pital during the 3-year study period from January 2011 to December 
2013. During the study period, six blood parameters including hemo-
globin concentration, platelet count, prothrombin time international 
normalized ratio (PT-INR), fibrinogen concentration, antithrom-
bin (AT) activity, and D-dimer were determined twice at GW 29–32 
(defined as mid-pregnancy in this study) and GW 35–37 (defined as 
pre-delivery). Finally, 1032 women with blood data available both 
at mid-pregnancy and pre-delivery were included in this study after 
excluding 315 women (Figure 1). All blood variables were determined 
at Tsukuba i-laboratory LLP immediately after sampling. Fibrinogen 
concentrations in plasma were determined with the Clauss method.
Maternal clinical demographic data including body mass index 
(BMI, kg/m2) on admission for childbirth, parity, complications of 
pregnancy, GW at delivery, and estimated blood loss (EBL) in the 2 h 
after delivery were collected from medical charts. PPH was defined as 
EBL  ≥ 700 mL in this study.
Statistical analyses
Data were analyzed using SPSS software version 22 (IBM). Student’s 
t-test and the Mann-Whitney U-test were used for the comparison of 
means and median. The χ2 test and Fisher’s exact test were used for 
the comparison of categorical data. Linear regression analysis was 
performed using Spearman’s rank correlation coefficient. Categorized 
variables were converted to dummy variables for the univariate and 
multivariate logistic regression analyses. The cut-off levels for contin-
uous variables included 35 years for maternal age, 28.2 kg/m2 for BMI 
according to the definition of obese pregnant women proposed by 
the Japan Society for the Study of Obesity [11], 1.0 for PT-INR at both 
mid-pregnancy and pre-delivery (corresponding to approximately 
75th percentile values for both pregnancy stages in our population), 
3.8 g/L and 4.0 g/L for fibrinogen at mid-pregnancy and pre-delivery, 
respectively (corresponding to approximately 15th percentile values 
for each pregnancy stage in our population), 90% and 85% of nor-
mal activity level for AT activity at mid-pregnancy and pre-delivery, 
respectively (corresponding to approximately 15th percentile values 
for each pregnancy stage in our population), and 1.9  μg/mL and 
2.7 μg/mL for D-dimer at mid-pregnancy and pre-delivery, respec-
tively (corresponding to approximately 75th percentile values for each 
pregnancy stage in our population). Multivariate logistic regression 
analysis was used to determine independent risk factors for PPH and 
calculate adjusted odds ratio. In all analyses, P-values  < 0.05 were 
considered statistically significant.
Results
PPH occurred in 104 of 1032 women (10%) (Table 1). The 
mean maternal age and antenatal BMI determined on 
admission for childbirth differed significantly between the 
two groups. A significantly larger number of women had 
a history of previous cesarean delivery in the PPH group 
than in the non-PPH group. Therefore, the three factors 
of maternal age, maternal BMI, and previous cesarean 
delivery were candidate independent risk factors for PPH 
among demographic characteristics.
Blood test results were compared between the two 
groups with and without PPH (Table 2). Among six blood 
variables, the mean AT activity level was significantly 
and consistently lower and the mean D-dimer level was 
significantly and consistently higher in the PPH group 
than in the non-PPH group at both mid-pregnancy and 
pre-delivery (Table 2). In addition, the number of women 
with lower fibrinogen levels, lower AT activity levels, and 
higher D-dimer levels was consistently and significantly 
Figure 1: Flow diagram for participant selection.
Among 1347 candidates for this study, a total of 315 women were 
excluded from the present analysis: three with stillbirths; 29 with 
known hematologic abnormalities including 10 with idiopathic 
thrombocytopenic purpura, five with anti-phospholipid syndrome 
treated with low-dose aspirin, five with a history of thrombosis 
requiring anti-coagulation with heparin, two with myelodysplastic 
syndrome, two with protein S deficiency, and one each with familial 
antithrombin deficiency, aplastic anemia, thalassemia, recurrent 
miscarriage treated with aspirin, and transverse sinus thrombosis; 
282 who underwent blood testing only once at either mid-pregnancy 
(gestational week 29–32) or pre-delivery (gestational week 35–37); 
and one with two outliers in the blood test results. The remaining 
1032 women with available blood data from both the mid-pregnancy 
and pre-delivery periods were analyzed in this study.
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greater in the PPH group than in the non-PPH group at both 
mid-pregnancy and pre-delivery (Table  3). The number 
of women  ≥ 35  years of age, with BMI  > 28.2  kg/m2, and 
with previous cesarean delivery was significantly greater 
in the PPH group than in the non-PPH group (Table  3). 
Thus, nine factors including maternal age  ≥ 35  years, 
maternal BMI  > 28.2 kg/m2, previous cesarean delivery, 
fibrinogen  < 3.8 g/L at mid-pregnancy and  < 4.0 g/L at pre-
delivery, AT activity  < 90% at mid-pregnancy and  < 85% at 
pre-delivery, and D-dimer  ≥ 1.9 μg/mL at mid-pregnancy 
and  ≥ 2.7 μg/mL at pre-pregnancy were candidate inde-
pendent risk factors for PPH.
As expected, a strong correlation was confirmed 
between the two data sets concerning fibrinogen levels, AT 
activity levels, and D-dimer levels determined at mid-preg-
nancy and pre-delivery; correlation coefficients (r) were 
0.714 for fibrinogen levels, 0.76 for AT activity levels, and 
0.873 for D-dimer levels determined at the two pregnancy 
stages. However, no significant correlations were observed 
among these three blood variables at mid-pregnancy 
as well as pre-delivery period. Fibrinogen and D-dimer 
increased significantly, and AT activity decreased sig-
nificantly with advancing gestation (all P-values  < 0.001). 
Therefore, multivariate logistic regression analysis was 
performed separately for the mid-pregnancy and pre-deliv-
ery data. In both analyses, three factors including mater-
nal age  ≥ 35 years (Yes or No), BMI  > 28.2 kg/m2 (Yes or No), 
and previous cesarean delivery (Yes or No) were entered. 
In addition, fibrinogen  < 3.8 g/L at mid-pregnancy (Yes or 
No), AT activity  < 90% at mid-pregnancy (Yes or No), and 
D-dimer  ≥ 1.9 μg/mL at mid-pregnancy (Yes or No) were 
entered in the first analysis, and fibrinogen  < 4.0  g/L at 
Table 1: Clinical characteristics of the two groups.
  PPH group (n = 104)  Non-PPH group (n = 928)  P-value
Maternal age (years)   34  [19–43]  32  [14–47]  0.036
Antenatal BMI (kg/m2)   26.1  [20.1–51.2]  25.2  [18.2–52.5]  0.001
Nulliparous   62  (59.6%)  503  (54.2%)  0.293
Previous cesarean delivery  12  (11.5%)  59  (6.4%)  0.048
Complications          
 PIH   5  (4.8%)  17  (1.8%)  0.062
 DM/GDM   21  (20.2%)  186  (20.0%)  0.971
 Uterine fibroma   4  (3.8%)  64  (6.9%)  0.234
Data are presented as median [range], or number (%).
BMI = Body mass index, PIH = pregnancy-induced hypertension including preeclampsia and gestational hypertension, DM/GDM = diabetes 
mellitus/gestational diabetes mellitus.
Table 2: Comparison of blood test results between the two groups.
 
 
PPH group (n = 104) 
 
Non-PPH group (n = 928) 
 
P-value
Mean±SD or median  range Mean±SD or median  range
Mid-pregnancy (GW 29–32)         
 Hemoglobin (g/dL)   11.0±0.96  9.1–13.3  11.2±0.85  8.1–14.4  0.596
 Platelets (109/L)   228.7±63.4  96–390  225.7±49.8  88–439  0.647
 PT-INR   0.98±0.06  0.84–1.21  0.98±0.05  0.84–1.28  0.160
 Fibrinogen (g/L)   4.55±0.89  2.76–7.17  4.54±0.75  2.47–7.93  0.945
 AT activity (%)   99.1±11.0  72.0–132.2  101.3±10.1  72.5–142.1  0.040
 D-dimer (μg/mL)   1.7  0.7–9.8  1.4  0.4–9.2   < 0.001a
Pre-delivery (GW 35–37)          
 Hemoglobin (g/dL)   11.1±0.89  9.1–14.2  11.1±0.86  8.3–15.1  0.778
 Platelets (109/L)   220.8±60.6  35–371  221.5±52.3  73–443  0.918
 PT-INR   0.97±0.05  0.87–1.14  0.96±0.05  0.79–1.26  0.120
 Fibrinogen (g/L)   4.64±0.82  3.10–6.63  4.73±0.74  2.70–7.55  0.258
 AT activity (%)   96.2±11.5  59.4–126.6  98.3±10.8  66.7–141.4  0.060
 D-dimer (μg/mL)   2.2  0.8–11.6  1.9  0.6–12.8  0.001a
Mean and median values were compared between the two groups using Student’s t-test and aMann-Whitney U-test, respectively.
GW = Gestational week, PT-INR = prothrombin time international normalized ratio, AT = antithrombin.
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pre-delivery (Yes or No), AT activity  < 85% at pre- delivery 
(Yes or No), and D-dimer  ≥ 2.7  μg/mL at pre-delivery 
(Yes or No) were entered in the second analysis. In both 
analyses, maternal age  ≥ 35 years, BMI  > 28.2  kg/m2, 
and previous cesarean delivery were identified as inde-
pendent risk factors for PPH, increasing the risk of PPH 
by approximately 70%, 100%, and 180%, respectively 
(Table 4). Fibrinogen  < 3.8 g/L and D-dimer  ≥ 1.9 μg/mL 
at mid-pregnancy were independent risk factors for PPH, 
and all three blood variables, fibrinogen  < 4.0 g/L, AT 
activity  < 85%, and D-dimer  ≥ 2.7 μg/mL at pre-delivery, 
were significant independent risk factors for PPH, increas-
ing the risk of PPH by approximately 100%, 80%, and 
100%, respectively (Table 4).
Participants were divided into quintile groups accord-
ing to fibrinogen, AT activity, and D-dimer levels at GW 
35–37 (Figure 2). As expected, the PPH prevalence rate 
was highest in the 1st quintile groups of fibrinogen and AT 
activity levels and the 5th quintile group of D-dimer level.
Discussion
To our knowledge, this study demonstrated for the first 
time that three blood variables, fibrinogen, AT activity, 
and D-dimer, in late gestation were independent risk 
factors for PPH. D-dimer level as well as fibrinogen level 
in mid-pregnancy were also independent risk factors for 
PPH in this study. Maternal age  ≥ 35, BMI  > 28.2 kg/m2, 
and history of cesarean delivery were confirmed as risk 
factors, as reported previously by several studies [12–17].
Table 3: Categorized characteristics in the two groups.
  PPH group (n = 104)  Non-PPH group (n = 928)  P-value
Maternal age  ≥ 35   48  (46)  330  (36)  0.033
BMI  > 28.2   29  (28)  185  (20)  0.058
Nulliparous   62  (60)  505  (54)  0.293
Previous cesarean delivery   12  (12)  59  (6)  0.048
Mid-pregnancy (GW 29–32)          
 PT-INR  ≥ 1.0   39  (38)  306  (33)  0.354
 Fibrinogen  < 3.8 g/L   26  (25)  139  (15)  0.008
 AT activity  < 90%   22  (21)  120  (13)  0.021
 D-dimer  ≥ 1.9 μg/mL   46  (44)  234  (25)   < 0.001
Pre-delivery (GW 35–37)          
 PT-INR  ≥ 1.0   30  (29)  207  (22)  0.133
 Fibrinogen  < 4.0 g/L   26  (25)  139  (15)  0.008
 AT activity  < 85%   20  (19)  94  (10)  0.005
 D-dimer  ≥ 2.7 μg/mL   36  (35)  198  (21)  0.002
Number of women (percentage) is indicated.
BMI = Body mass index, GW = gestational week, PT-INR = prothrombin time international normalized ratio, AT = antithrombin.
Table 4: Results of multivariate logistic regression analyses.
  aOR (95% CI)  P-value
Mid-pregnancy (GW 29–32)   
 Age  ≥ 35 years   1.77 (1.16–2.71)  0.009
 BMI  > 28.2 kg/m2   2.02 (1.24–3.28)  0.004
 Previous cesarean   2.91 (1.37–6.18)  0.005
 Fibrinogen  < 3.8 g/L   1.83 (1.09–3.07)  0.022
 AT activity  < 90%   1.62 (0.94–2.79)  0.081
 D-dimer  ≥ 1.9 μg/mL   2.59 (1.68–3.99)   < 0.001
Pre-delivery (GW 35–37)    
 Age  ≥ 35 years   1.75 (1.15–2.68)  0.009
 BMI  > 28.2 kg/m2   1.95 (1.20–3.16)  0.007
 Previous cesarean   2.77 (1.31–5.83)  0.007
 Fibrinogen  < 4.0 g/L   1.96 (1.18–3.27)  0.010
 AT activity  < 85%   1.84 (1.05–3.21)  0.032
 D-dimer  ≥ 2.7 μg/mL   2.03 (1.29–3.19)  0.002
aOR (95% CI) = Adjusted odds ratio (95% confidence interval), 
BMI = body mass index, GW = gestational week, AT = antithrombin.
The D-dimer level increased significantly with advanc-
ing gestation in this study, consistent with results of 
previous studies [18]. Therefore, in the present study, dif-
ferent cut-off levels for D-dimer were set in the two periods, 
i.e.  ≥ 1.9 μg/mL at mid-pregnancy and  ≥ 2.7 μg/mL at pre-
delivery, corresponding to the 73rd (752/1032, Table 3) and 
77th (798/1032, Table 3) percentile values, respectively, in our 
population. These cut-off levels predicted the risk of PPH 
independently of other risk factors. Higher D-dimer level is 
seen at the early stage of PPH [9]. However, to our knowl-
edge, no previous studies have focused on the association 
between antenatal D-dimer levels and PPH occurrence.
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It was expected that higher D-dimer was a risk factor 
of PPH. A significant negative correlation is seen between 
fibrinogen and D-dimer levels in late twin gestation, in 
which an exaggerated coagulation response has been sug-
gested [19] based on the finding that D-dimer level is sig-
nificantly higher and fibrinogen is significantly lower in 
late twin gestation than in late singleton gestation [18, 19]. 
In addition, a low fibrinogen level at the initial phase of 
PPH increases the risk of severe PPH [9, 10], and low ante-
natal fibrinogen level increases the risk of PPH [20,  21], 
as was confirmed in this study. Thus, as the increase in 
D-dimer may have reflected enhanced fibrinolysis, i.e. 
consumption of fibrinogen leading to lower fibrinogen 
level, higher D-dimer level was expected to be a risk factor 
for PPH. An increase of fibrinogen up to two-fold of the 
non-pregnant level [19] may be a physiologic adaption to 
hyperconsumption of fibrinogen occurring in pregnancy, 
as evidenced by higher D-dimer levels in pregnant women 
than in non-pregnant women [18]. However, no significant 
correlation was seen between fibrinogen and D-dimer 
levels in this study, consistent with results of the previ-
ous study in singleton pregnancies by Yamada et al. [19]. 
Even in the presence of fibrinogen hyperconsumption, a 
low fibrinogen level theoretically does not occur when 
the production of fibrinogen compensates its consump-
tion. The absence of a significant correlation between 
fibrinogen and D-dimer levels in late singleton gestation 
may be explained by milder hyperconsumption of fibrin-
ogen in singleton pregnancies compared to that in twin 
pregnancies.
AT activity decreased significantly with advancing 
gestation in this study, consistent with the results of a pre-
vious study [22], and was an independent risk factor for 
PPH in this study. As AT is the most important molecule 
for anti-coagulation in the circulating blood, combining 
with thrombin at a 1:1 ratio, the decreased AT activity may 
suggest exaggerated thrombin generation. Blood coagula-
tion occurs in the presence of thrombin. Thus, both the 
lower AT activity and higher D-dimer level occur as a 
result of enhanced coagulation. Our findings that higher 
D-dimer level, lower fibrinogen level, and lower AT activity 
level were risk factors for PPH imply that enhanced coag-
ulation leading to lower levels of fibrinogen, AT activity, 
and/or D-dimer increased the risk of PPH. We speculate 
that some women with such characteristics appearing in 
blood test results may have experienced additional blood 
loss to the usual blood loss, thus reaching EBL meeting 
the criteria for PPH due to hematologic problems associ-
ated with the hypercoagulable state in pregnancy.
In this study, advanced maternal age ( ≥ 35 years) and 
meeting the Japanese obesity threshold (BMI  > 28.2 kg/m2) 
immediately before childbirth were independent risk 
factors of PPH, consistent with results of previous studies 
[12–15]. Previous cesarean delivery was also an independ-
ent risk factor of PPH, perhaps due to mechanical problems 
with respect to uterine contraction after vaginal delivery.
This study has some limitations. First, University of 
Tsukuba Hospital is one of the largest perinatal medical 
centers in Ibaraki prefecture, so cases largely involved 
complicated pregnancies and primiparous women of 
advanced maternal age. Second, the ethnic distribution of 
patients was biased toward Asian and Hispanic, and these 
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Figure 2: Prevalence rate of PPH in the quintile groups divided 
by fibrinogen, AT activity, and D-dimer levels at gestational week 
35–37.
One thousand and thirty-two women were divided into quintile 
groups by fibrinogen level at GW 35–37 (upper panel), AT activity 
level at gestational week 35–37 (middle panel), and D-dimer level 
at gestational week 35–37 (lower panel). The cut-off values for 
quintiles were 4.12, 4.50, 4.88, and 5.36 g/L for fibrinogen; 89, 
95,100, and 107% for AT activity, and 1.5, 1.8, 2.2, and 2.9 μg/mL for 
D-dimer. The actual number of women in each quintile is indicated 
above each bar. The Jonckheere- Terpstra trend test indicated that 
quintile groups included different groups with respect to both 
the distribution of EBL and the prevalence rate of PPH (P < 0.001); 
†, P < 0.05 vs. the 1st quintile group with respect to EBL. ‡, P < 0.05 vs. 
the 1st quintile group with respect to the prevalence rate of PPH.
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ethnicities are risk factors of uterine atony [2, 15]. Third, 
women who did not have regular antenatal checkups were 
excluded, and this group is considered to be at high risk 
for PPH. Finally, the cost effectiveness of prenatal screen-
ing of D-dimer or fibrinogen solely for the prediction of 
PPH might be controversial.
Conclusion
This study demonstrated higher D-dimer level as well as 
lower fibrinogen and AT activity levels in late gestation 
were independent risk factors for PPH. Although the precise 
mechanisms leading to PPH remain unclear at present, 
our results suggested that a state of enhanced coagulation 
leading to higher D-dimer level, lower AT activity level, 
and/or lower fibrinogen level contributed to increased risk 
of PPH in some pregnant women with such characteristics 
on blood test results. Term pregnant women found inci-
dentally to have such a status with enhanced coagulation 
should be cared with extra caution against PPH.
Disclosure: We have no circumstances of conflict of inter-
est that should be disclosed. We have not received any 
financial support regarding this study.
References
[1] Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PFA. WHO 
analysis of causes of maternal death: a systematic review. 
Lancet. 2006;367:1066–74.
[2] Royal College of Obstetricians and Gynaecologists. Postpartum 
haemorrhage, prevention and management (Green-top Guide-
line No. 52) [Internet] 2009.
[3] Japan Society of Obstetrics and Gynecology, The report of 83 cases 
of maternal mortality in 2010–2012 [Internet] 2013. Available from: 
http://www.jaog.or.jp/all/document/67_130710.pdf (Japanese).
[4] Japanese Ministry of Health, Labour and Welfare. Change in 
maternal mortality rate in Japan [Internet]. Available from: 
http://www.mhlw.go.jp/english/database/db-hh/xls/2-18.xls.
[5] Japan Society of Obstetrics and Gynecology, The report of the 
prenatal committee in 2013 [Internet] 2014. Available from: 
http://fa.kyorin.co.jp/jsog/readPDF.php?file=66/6/066061450.
pdf (Japanese).
[6] United Nations Population Fund. By choice, not by chance:  family 
planning, human rights and development. New York: UNFPA; 2012.
[7] Knight M, Callaghan WM, Berg C, Alexander S, Bouvier-Colle MH, 
Ford JB, et al. Trends in postpartum hemorrhage in high 
resource countries: a review and recommendations from the 
International Postpartum Hemorrhage Collaborative Group. BMC 
Pregnancy Childbirth. 2009;9:55.
[8] Japanese Ministry of Health, Labour and Welfare. Vital 
statistics of population. [Internet] 2013. Available from: 
http://www.mhlw.go.jp/toukei/saikin/hw/hoken/kiso/21.html 
(Japanese).
[9] Charbit B, Mandelbrot L, Samain E, Baron G, Haddaoui B, 
Keita H, et al. The decrease of fibrinogen is an early predictor 
of the severity of postpartum hemorrhage. J Thromb Haemost. 
2007;5:266–73.
[10] Cortet M, Deneux-Tharaux C, Dupont C, Colin C, Rudigoz RC, 
Bouvier-Colle MH, et al. Association between fibrinogen level 
and severity of postpartum haemorrhage: secondary analysis 
of a prospective trial. Br J Anaesth. 2012;108:984–9.
[11] Japan Society for the Study of Obesity. Guidelines for the 
 management of obesity disease 2006. Himan Kenkyu. 
2006;12(suppl):1–91. [Japanese].
[12] Matsuda Y, Kawamichi Y, Hayashi K, Shiozaki A, Satoh S,  
Saito S. Impact of maternal age on the incidence of obstetrical 
complications in Japan. J Obstet Gynaecol Res. 2011;37: 
1409–14.
[13] Jolly M, Sebire N, Harris J, Robinson S, Regan L. The risks asso-
ciated with pregnancy in women aged 35 years or older. Hum 
Reprod. 2000;15:2433–7.
[14] Magann EF, Doherty DA, Sandlin AT, Chauhan SP, Morrison JC. 
The effects of an increasing gradient of maternal obe-
sity on pregnancy outcomes. Aust N Z J Obstet Gynaecol. 
2013;53:250–7.
[15] Wetta LA, Szychowski JM, Seals S, Mancuso MS, Biggio JR, 
Tita AT. Risk factors for uterine atony/postpartum hemorrhage 
requiring treatment after vaginal delivery. Am J Obstet Gynecol. 
2013;209:51.e1–6.
[16] Ford JB, Roberts CL, Simpson JM, Vaughan J, Cameron CA. 
Increased postpartum hemorrhage rates in Australia. Int J 
Gynaecol Obstet. 2007;98:237–43.
[17] Joseph KS, Rouleau J, Kramer MS, Young DC, Liston RM, 
Baskett TF, et al. Investigation of an increase in postpartum 
haemorrhage in Canada. Br J Obstet Gynaecol. 2007;114: 
751–9.
[18] Yamada T, Kawaguchi S, Araki N, Takeda M, Nishida R, Yamada 
T, et al. Difference in the D-dimer rise between women with 
singleton and multifetal pregnancies. Thromb Res. 2013;131: 
493–6.
[19] Yamada T, Morikawa M, Yamada T, Akaishi R, Kojima T, 
Minakami H. Fibrinogen levels in the late stage of twin preg-
nancy. Thromb Res. 2015;135:318–21.
[20] Simon L, Santi TM, Sacquin P, Hamza J. Pre-anaesthetic 
assessment of coagulation abnormalities in obstetric patients; 
usefulness, timing and clinical implications. Br J Anaesth. 
1997;78:678–83.
[21] Yamada T, Akaishi R, Oda Y, Nishida R, Yamada T, Ishikawa S, 
et al. Antenatal fibrinogen concentrations and postpartum 
haemorrhage. Int J Obstet Anesth. 2014;23:365–70.
[22] Tsunoda T, Ohkuchi A, Izumi A, Watanabe T, Matsubara S, 
Sato I, et al. Antithrombin III activity and platelet count are 
more likely to decrease in twin pregnancies than in singleton 
pregnancies. Acta Obstet Gynecol Scand. 2002;81:840–5.
The authors stated that there are no conflicts of interest regarding 
the publication of this article.
Brought to you by | Bibl. Scienze della Storia e Docum.
Authenticated | manobata@md.tsukuba.ac.jp author's copy
Download Date | 6/8/16 12:32 PM
